Back to top

Briumvi’s Rapid Commercial Momentum and Upward Sales Guidance Underpin Bancroft’s Buy Rating

TD Cowen analyst Tara Bancroft has maintained their bullish stance on TGTX stock, giving a Buy rating yesterday. Tara Bancroft has given his Buy ra...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

TG Therapeutics, Inc. (TGTX)